Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma

Souichi Yanamoto, Shigeto Yamada, Hidenori Takahashi, +9

International Journal of Oral and Maxillofacial Surgery

Tumor BiologyClinicopathological Risk FactorsMedicineCancer RecurrencePathology +8

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne, +1637

The Lancet Diabetes & Endocrinology

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Hiroki Izumi, Shingo Matsumoto, Jie Liu, +35

Nature

Oncogenic AgentMedicineNon‐small‐cell Lung CancerPathologyCancer Cell Biology +8

A clinicopathological study of perineural invasion and vascular invasion in oral tongue squamous cell carcinoma

Yuki Matsushita, Souichi Yanamoto, Hiroshi Takahashi, +9

International Journal of Oral and Maxillofacial Surgery

Perineural InvasionOral CavityVascular InvasionPathologyDermatology +5

Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study

Kaho Miura, Yoshiyuki Sano, Seiji Niho, +12

Thoracic Cancer

Proteasome Inhibition Overcomes ALK-TKI Resistance in <i>ALK</i> -Rearranged/ <i>TP53</i> -Mutant NSCLC via Noxa Expression

Azusa Tanimoto, Shingo Matsumoto, Shinji Takeuchi, +10

Clinical Cancer Research

Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma

Nanae Tomonaga, Yoichi Nakamura, Hiroyuki Yamaguchi, +10

Clinical Lung Cancer

Tumor HeterogeneityMedicinePathologyBronchial NeoplasmEgfr Mutations +8

Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia study

Yutaro Tamiya, Shingo Matsumoto, Yoshitaka Zenke, +18

Lung Cancer

Large-scale Clinico-genomic ProfileKras G12cTumor HeterogeneityMedicinePathology +9

Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)

Minoru Fukuda, Takeshi Kitazaki, Daiki Ogawara, +14

Lung Cancer

OncologyElderly PatientsAdvanced Lung DiseaseClinical TrialsPathology +7

Alert Regarding Cisplatin-induced Severe Adverse Events in Cancer Patients with Xeroderma Pigmentosum

Makoto Sumiyoshi, Hiroshi Soda, Noriaki Sadanaga, +7

Internal Medicine

Xeroderma PigmentosumCddp-based ChemotherapyMedicineMetronomic TherapyPathology +8